Insider Trading & Ownership of James E. Flynn

Location
New York, NY
Summary
The estimated net worth of James E. Flynn is at least $2,328,194,988 dollars as of 02 Mar 2026. James E. Flynn is the Director, Director by Deputization, 10%+ Owner of Nuvalent, Inc. and owns shares of Nuvalent, Inc. (NUVL) stock worth about $1.64B. James E. Flynn is the 10%+ Owner of ARS Pharmaceuticals, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $180.44M. James E. Flynn is the Director, * Director by Deputization, 10%+ Owner of Larimar Therapeutics, Inc. and owns shares of Larimar Therapeutics, Inc. (LRMR) stock worth about $178.03M. James E. Flynn is the *Possible Member of 10% Group, 10%+ Owner of AdaptHealth Corp. and owns shares of AdaptHealth Corp. (AHCO) stock worth about $141.86M. James E. Flynn is the * Possible Member of 10% Group, 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $90.96M. James E. Flynn is the Director, Director by Deputization, 10%+ Owner of CareMax, Inc. and owns shares of CareMax, Inc. stock worth about $54.75M. James E. Flynn is the Possible Members of 10% Group, 10%+ Owner of Bicara Therapeutics Inc. and owns shares of Bicara Therapeutics Inc. (BCAX) stock worth about $23.77M. James E. Flynn is the Director, Director by deputization of Acutus Medical, Inc. and owns shares of Acutus Medical, Inc. stock worth about $4.16M. James E. Flynn is the Possible Member of 10% Group, 10%+ Owner of PepGen Inc. and owns shares of PepGen Inc. (PEPG) stock worth about $3.97M. James E. Flynn is the *Possible Member of 10% Group, 10%+ Owner of Singular Genomics Systems, Inc. and owns shares of Singular Genomics Systems, Inc. stock worth about $3.89M. James E. Flynn is the Possible Members of 10% Group, 10%+ Owner of Fractyl Health, Inc. and owns shares of FRACTYL HEALTH, INC. (GUTS) stock worth about $2.42M. James E. Flynn is the Director, *Director by Deputization of BiomX Inc. and owns shares of BiomX Inc. (PHGE) stock worth about $2.32M. James E. Flynn is the Possible Member of 10% Group, 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $1.9M. James E. Flynn is the Possible Members of 10% Group, 10%+ Owner of Oncology Institute, Inc. and owns shares of Oncology Institute, Inc. (TOI) stock worth about $448.3K.
Signature
/s/ Jonathan Isler, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow James E. Flynn and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • James E. Flynn has 16 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,328,194,988.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Nuvalent, Inc. ($1,639,268,060).
  • Past-year value change for that position: -$70,874,975.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of James E. Flynn

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NUVL Nuvalent, Inc. Director, Director by Deputization, 10%+ Owner $1,639,268,060 -$70,874,975 -4.1% 24 Nov 2025
SPRY ARS Pharmaceuticals, Inc. 10%+ Owner $180,437,416 -$13,663,151 -7% 27 Jun 2025
LRMR Larimar Therapeutics, Inc. Director, * Director by Deputization, 10%+ Owner $178,034,870 +$55,000,000 +45% 27 Feb 2026
AHCO AdaptHealth Corp. *Possible Member of 10% Group, 10%+ Owner $141,859,958 08 Mar 2024
MIRM Mirum Pharmaceuticals, Inc. * Possible Member of 10% Group, 10%+ Owner $90,958,032 06 Jun 2022
CMAX CareMax, Inc. Director, Director by Deputization, 10%+ Owner $54,748,317 17 Nov 2023
BCAX Bicara Therapeutics Inc. Possible Members of 10% Group, 10%+ Owner $23,774,208 17 Sep 2024
AFIB Acutus Medical, Inc. Director, Director by deputization $4,163,964 27 Jan 2025
PEPG PepGen Inc. Possible Member of 10% Group, 10%+ Owner $3,971,852 10 May 2022
OMIC Singular Genomics Systems, Inc. *Possible Member of 10% Group, 10%+ Owner $3,891,028 01 Jun 2021
GUTS Fractyl Health, Inc. Possible Members of 10% Group, 10%+ Owner $2,419,003 06 Feb 2024
PHGE BiomX Inc. Director, *Director by Deputization $2,321,016 21 Apr 2025
XLO Xilio Therapeutics, Inc. Possible Member of 10% Group, 10%+ Owner $1,898,994 26 Oct 2021
TOI, DFPH Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner $448,270 12 Nov 2021
FLAC Frazier Lifesciences Acquisition Corp Possible Member of 10% Group, 10%+ Owner 08 Nov 2022
ONCR Oncorus, Inc. Possible Member of 10% Group, 10%+ Owner 28 Dec 2022

Insider Transactions Reported by James E. Flynn:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.